Statistics for BIPSE: A Biomarker-based Phase I/II Design for Immunotherapy Trials with Progression-free Survival Endpoint
Total visits
| views | |
|---|---|
| BIPSE: A Biomarker-based Phase I/II Design for Immunotherapy Trials with Progression-free Survival Endpoint | 5 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:abb5b675-4333-4d84-b9a3-c6c126d9240b | 46 |
| nihms-1823068.pdf | 17 |
| java.util.UUID:25ad2fe1-b328-4e65-bf0b-7f8acacb8af4 | 17 |
| java.util.UUID:33bc3ce3-7a68-47ef-9c05-058837b64499 | 12 |
Top country views
| views | |
|---|---|
| United States | 4 |
| India | 1 |
Top city views
| views | |
|---|---|
| Greenwood | 3 |
| Ashburn | 1 |